Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Neuroprotective function of R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, [R-(-)-BPAP], against apoptosis induced by N-methyl(R)salsolinol, an endogenous dopaminergic neurotoxin, in human…
- W. Maruyama, H. Yi, +5 authors M. Naoi
- Biology, Medicine
- Life sciences
- 21 May 2004
R-(-)-1-(Benzofuran-2-yl)-2-propylaminopentane HCl [R-(-)-BPAP] is one of "catecholaminergic and serotonergic enhancers", which were proposed to improve symptoms through increase in impulse-evoked… Expand
Antidepressant-like effects of selegiline in the forced swim test
- S. Shimazu, Akiko Minami, H. Kusumoto, F. Yoneda
- Medicine, Psychology
- European Neuropsychopharmacology
- 1 October 2005
Although selegiline, a monoamine oxidase (MAO)-B inhibitor, is reported to exert antidepressant effects in depressant patients, evidence in rodents for effects of selegiline is quite limited. The… Expand
Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35)
- H. Tsunekawa, Y. Noda, A. Mouri, F. Yoneda, T. Nabeshima
- Psychology, Medicine
- Behavioural Brain Research
- 19 July 2008
Selegiline, an irreversible inhibitor of monoamine oxidase B used in the treatment of Parkinson's disease, has been demonstrated to have a potential cognition-improving effect in patients with… Expand
(−)1‐(Benzofuran‐2‐yl)‐2‐propylaminopentane, [(−)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain
- J. Knoll, F. Yoneda, B. Knoll, H. Ohde, I. Miklya
- Chemistry, Medicine
- British journal of pharmacology
- 1 December 1999
The brain constituents β‐phenylethylamine (PEA) and tryptamine enhance the impulse propagation mediated transmitter release (exocytosis) from the catecholaminergic and serotoninergic neurons in the… Expand
Retinal neuronal death induced by intraocular administration of a nitric oxide donor and its rescue by neurotrophic factors in rats.
- K. Takahata, H. Katsuki, +7 authors A. Akaike
- Biology, Medicine
- Investigative ophthalmology & visual science
- 1 April 2003
PURPOSE
To investigate the neurotoxic outcome in the rat retina exposed to nitric oxide (NO) released from an NO donor and to evaluate the effects of neurotrophic factors on the survival of… Expand
Effects of selegiline alone or with donepezil on memory impairment in rats.
- K. Takahata, Akiko Minami, H. Kusumoto, S. Shimazu, F. Yoneda
- Medicine, Psychology
- European journal of pharmacology
- 22 August 2005
Selegiline, a monoamine oxidase-B inhibitor, is reported to improve memory and learning in dementia of Alzheimer's type. However, only a few studies have reported its use in animal models. Here, we… Expand
Protective effects of selegiline and desmethylselegiline against N-methyl-D-aspartate-induced rat retinal damage.
- K. Takahata, H. Katsuki, +6 authors A. Akaike
- Medicine
- European journal of pharmacology
- 2003
Selegiline, a therapeutic agent of Parkinson's disease, and its metabolite, desmethylselegiline, were explored for their neuroprotective effects against N-methyl-D-aspartate (NMDA)-induced cell death… Expand
Effects of monoamine oxidase inhibitors on the diethyldithiocarbamate-induced enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in C57BL/6 mice
- K. Takahata, S. Shimazu, F. Yoneda, M. Ogawa, Y. Iida, H. Saji
- Chemistry, Medicine
- Journal of Neural Transmission
- 1 August 2003
Summary. Diethyldithiocarbamate (DDC) is known to potentiate the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The aims of the present study were to provide biochemical,… Expand
Excavations at Saheth Maheth 1986-1996
Les AA presentent ici les resultats des fouilles effectuees sur le site de Saheth Maheth, en Inde, au cours de la periode 1986-1996. Ce site a ete identifie avec l'un des lieux saints du Bouddhisme :… Expand
- 4
- 1
Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and…
- F. Yoneda, T. Moto, +4 authors J. Knoll
- Chemistry, Medicine
- Bioorganic & medicinal chemistry
- 1 May 2001
The catecholaminergic and serotoninergic neurons in the brain change their performance according to the physiological need via a catecholaminergic/serotoninergic activity enhancer (CAE/SAE)… Expand